EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Grape seed proanthocyanidin extract targets p66Shc to regulate mitochondrial biogenesis and dynamics in diabetic kidney disease

Yiyun Song, Hui Yu, Qiaoling Sun, Fei Pei, Qing Xia, Zhaoli Gao, Xianhua Li

Frontiers in Pharmacology · 06.01.2023 · 13

DOI: 10.3389/fphar.2022.1035755 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 06.01.2023. Verfasst von Yiyun Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial biogenesis and dynamics are associated with renal mitochondrial dysfunction and the pathophysiological development of diabetic kidney disease (DKD). Decreased p66Shc expression prevents DKD progression by significantly regulating mitochondrial function. Grape seed proanthocyanidin extract (GSPE) is a potential therapeutic medicine for multiple kinds of diseases. The effect of GSPE on the mitochondrial function and p66Shc in DKD has not been elucidated. Hence, we decided to identify p66Shc as a therapeutic target candidate to probe whether GSPE has a renal protective effect in DKD and explored the underlying mechanisms.

Methods

In vivo , rats were intraperitoneally injected with streptozotocin (STZ) and treated with GSPE. Biochemical changes, mitochondrial morphology, the ultrastructure of nephrons, and protein expression of mitochondrial biogenesis (SIRT1, PGC-1α, NRF1, TFAM) and dynamics (DRP1, MFN1) were determined. In vitro , HK-2 cells were transfected with p66Shc and treated with GSPE to evaluate changes in cell apoptosis, reactive oxygen species (ROS), mitochondrial quality, the protein expression.

Results

In vivo , GSPE significantly improved the renal function of rats, with less proteinuria and a lower apoptosis rate in the injured renal tissue. Besides, GSPE treatment increased SIRT1, PGC-1α, NRF1, TFAM, and MFN1 expression, decreased p66Shc and DRP1 expression. In vitro , overexpression of p66Shc decreased the resistance of HK-2 cells to high glucose toxicity, as shown by increased apoptosis and ROS production, decreased mitochondrial quality and mitochondrial biogenesis, and disturbed mitochondrial dynamic homeostasis, ultimately leading to mitochondrial dysfunction. While GSPE treatment reduced p66Shc expression and reversed these changes.

Conclusion

GSPE can maintain the balance between mitochondrial biogenesis and dynamics by negatively regulating p66Shc expression.

Schlagwörter

Stichwörter der Autor:innen

diabetic kidney diseasegrape seed proanthocyanidin extractmitochondrial biogenesismitochondrial dynamicsp66Shc

Autor:innen und Institutionen

  • Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • Department of Nephrology, Qilu Hospital of Shandong University (Qingdao), Qingdao, Shandong, China.

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Song, Y., Yu, H., Sun, Q., Pei, F., Xia, Q., Gao, Z., & Li, X. (2023). Grape seed proanthocyanidin extract targets p66Shc to regulate mitochondrial biogenesis and dynamics in diabetic kidney disease. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.1035755

Vancouver

Song Y, Yu H, Sun Q, Pei F, Xia Q, Gao Z, et al. Grape seed proanthocyanidin extract targets p66Shc to regulate mitochondrial biogenesis and dynamics in diabetic kidney disease. Frontiers in Pharmacology. 2023;13. doi:10.3389/fphar.2022.1035755

BibTeX
@article{Song2023,
  author = {Song, Yiyun and Yu, Hui and Sun, Qiaoling and Pei, Fei and Xia, Qing and Gao, Zhaoli and Li, Xianhua},
  title = {Grape seed proanthocyanidin extract targets p66Shc to regulate mitochondrial biogenesis and dynamics in diabetic kidney disease},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fphar.2022.1035755}
}
Kostenlos starten →